T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses (2020)
Attributed to:
A UK underpinning platform to study immunology and immunopathology of COVID-19:The UK Coronavirus Immunology Consortium
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2020.09.28.20202929
Publication URI: http://dx.doi.org/10.1101/2020.09.28.20202929
Type: Preprint